These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9345397)

  • 1. Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis.
    Grimaldi LM; Martino G
    Mult Scler; 1995; 1 Suppl 1():S38-43. PubMed ID: 9345397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
    Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.
    Martino G; Grohovaz F; Brambilla E; Codazzi F; Consiglio A; Clementi E; Filippi M; Comi G; Grimaldi LM
    Ann Neurol; 1998 Mar; 43(3):340-9. PubMed ID: 9506551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function.
    Bao JY; Huang Y; Wang F; Peng YP; Qiu YH
    Neuroimmunomodulation; 2007; 14(6):344-53. PubMed ID: 18463421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
    Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
    Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiologic correlates of a novel T lymphocyte gamma-interferon-activated Ca2+ influx in patients with relapsing-remitting multiple sclerosis.
    Martino G; Filippi M; Martinelli V; Brambilla E; Comi G; Grimaldi LM
    Neurology; 1996 May; 46(5):1416-21. PubMed ID: 8628492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells.
    Manicassamy S; Sadim M; Ye RD; Sun Z
    J Mol Biol; 2006 Jan; 355(3):347-59. PubMed ID: 16309697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis.
    Adikari SB; Pettersson A; Soderstrom M; Huang YM; Link H
    Scand J Immunol; 2004 Jun; 59(6):600-6. PubMed ID: 15182256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis.
    Martino G; Clementi E; Brambilla E; Moiola L; Comi G; Meldolesi J; Grimaldi LM
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4825-9. PubMed ID: 8197142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients.
    Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
    Eur Cytokine Netw; 2000 Dec; 11(4):677-81. PubMed ID: 11125313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.